Editorial Policy

Nexvora LLC publishes pharmaceutical news, analysis, and intelligence content. This Editorial Policy describes the standards we follow to ensure accuracy, independence, and transparency.

Editorial Independence

Our editorial team operates independently from advertising, sponsorship, and commercial sales functions. Sponsored content, when published, is clearly labeled as such and does not influence independent editorial coverage.

Sourcing and Verification

We prioritize:

• Primary regulatory sources (FDA, EMA, MHRA, and comparable agencies)
• Peer-reviewed publications and official company disclosures
• Cross-verification of claims before publication
• Clear attribution and links to original sources where available

See our Data Sources Policy for detailed attribution standards.

Corrections

We correct factual errors promptly upon discovery. Material corrections are noted on the affected page with the date of correction. To report an error, contact [email protected].

AI-Assisted Content

We may use AI tools to assist with research, summarization, and analysis. AI-assisted content is reviewed by human editors before publication. See our AI Usage Policy for details.

Conflicts of Interest

Contributors must disclose financial or professional relationships that could affect coverage. We do not accept payment for favorable editorial treatment.